Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial
The I-SPY COVID Consortium
Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Famotidine
100%
Celecoxib
88%
GS-5734
49%
Randomized Controlled Trials
47%
TAK-652
46%
apremilast
39%
dornase alfa
38%
Bradykinin Receptor Antagonists
37%
Clinical Trials Data Monitoring Committees
35%
icatibant
34%
Phosphodiesterase 4 Inhibitors
33%
Oxygen
33%
United States Dept. of Health and Human Services
32%
Medical Futility
32%
Deoxyribonucleases
29%
Bayes Theorem
28%
Intention to Treat Analysis
27%
Pandemics
24%
Proxy
24%
Mortality
23%
Biomedical Research
23%
Random Allocation
22%
Histamine
22%
Dexamethasone
21%
Sample Size
20%
Delivery of Health Care
14%
Morbidity
13%
Safety
13%
Pharmaceutical Preparations
9%
Therapeutics
3%